Related Experiment Video

Updated: Jun 14, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

[Retifanlimab in metastatic Merkel cell carcinoma in first line]

Clara Zucman-Rossi1, Lise Boussemart2

  • 1Service de dermatologie, Gustave-Roussy Cancer Campus, Villejuif, France.

Bulletin Du Cancer
|September 3, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Anti-PD-1Anti-PD1Carcinome de MerkelImmunotherapyImmunothérapieMerkel cell carcinoma

More Related Videos

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

Articles linked to this work by shared authors, journal, and citation graph.

Governing artificial intelligence in cancer care: Perspectives and recommendations from patient organizations and the MULTIR consortium.

Journal of cancer policy·2026

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Gut·2025

NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial.

Acta oncologica (Stockholm, Sweden)·2024

Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase).

Frontiers in oncology·2023

Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).

PloS one·2023

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Cancers·2023

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

Bulletin du cancer·2026

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Bulletin du cancer·2026

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Bulletin du cancer·2026

[Metastatic or unresectable recurrent anal canal cancer: Therapeutic approaches and emerging perspectives].

Bulletin du cancer·2026

[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?]

Bulletin du cancer·2026

[Management of chronic pulmonary GVH in 2025, indication for lung transplantation (SFGM-TC)].

Bulletin du cancer·2026

The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.

The Journal of allergy and clinical immunology·2026

Thymic stromal lymphopoietin as a therapeutic target for the treatment of eosinophilic esophagitis.

Clinical and translational gastroenterology·2026

Primary hepatic interdigitating dendritic cell sarcoma: A rarity unveiled.

Indian journal of pathology & microbiology·2026

Treatment Patterns, Outcomes and Survival Trends in T-Cell Prolymphocytic Leukemia: A Nationwide Population-Based Study in the Netherlands.

European journal of haematology·2026

Peritoneal Desmoplastic Small Round Cell Tumor on FDG PET/CT.

Clinical nuclear medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us